share_log

Immunovant: Q1 Earnings Insights

Immunovant: Q1 Earnings Insights

免疫药物:第一季度收益洞察
Benzinga Real-time News ·  2022/08/05 17:50

Immunovant (NASDAQ:IMVT) reported its Q1 earnings results on Friday, August 5, 2022 at 07:00 AM.

免疫抗体纳斯达克(股票代码:IMVT)于2022年8月5日(星期五)上午07:00公布了第一季度收益业绩。

Here's what investors need to know about the announcement.

以下是投资者需要知道的关于这一声明的信息。

Earnings

收益

Immunovant beat estimated earnings by 12.5%, reporting an EPS of $-0.35 versus an estimate of $-0.4.

免疫系统比预期收益高出12.5%,每股收益为-0.35美元,而预期为-0.4美元。

Revenue was down $0 from the same period last year.

营收比去年同期下降了0美元。

Past Earnings Performance

过去的盈利表现

Last quarter the company missed on EPS by $0.03 which was followed by a 4.85% drop in the share price the next day.

上个季度,该公司每股收益比预期低0.03美元,第二天股价下跌了4.85%。

To track all earnings releases for Immunovant visit their earnings calendar here.

要跟踪免疫系统的所有收益情况,请访问他们的收益日历。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成,并由编辑审阅。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发